FDA Inspection 973552 — Zhejiang Jiangbei Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Jiangbei Pharmaceutical Co., Ltd. on May 6, 2016 in Taizhou City. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 6, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou City (China)